References
- Frei E, III, Canellos G P. Dose: a critical factor in cancer chemotherapy. Am J Med 1980; 69: 585–594
- Lokich J, Anderson N. Carboplatin versus cisplatin in solid tumors: an analysis of the literature. Ann Oncol 1998; 9: 13–21
- Henderson I C, Berry D, Demetri G. Improved disease-free (DFS) and overall survival (OS) from the addition of sequential paclitaxel (T) but not from the escalation of doxoruhicin (A) dose level in the adjuvant chemotherapy of patients (PTS) with node-positive primary breast cancer (BC). Proc ASCO 1998; 17: 390A
- Lokich J J, Ahlgren J, Gullo J. A prospective randomized comparison of continuous infusional 5-fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study. JCO 1989; 7: 425–432
- Slevin M C, Clark P I, Osborne R K. A randomized trial to evaluate the effect of schedule on the activity of etoposide in small cell lung cancer. Proc Am Soc Clin Oncol 1986; 5: 175
- Lokich J, Anderson N, Bem M. Multi-day fractionated administration schedule for paclitaxel. Ann Oncol 1995; 6: 883–886
- Hainsworth J D, Burris HA, III, Erland J B. Phase I trial of docetaxel administered by weekly infusion in patients with advanced refractory cancer. J Clin Oncol 1998; 16: 2164–2168
- Bums H A, Rothenberg M L, Kuhn J G. Clinical trials with the topoisomerase I inhibitors. Semin Oncol 1992; 19: 663–669
- Curt G A, Collins J M. Clinical pharmacology of infusional chemotherapy. Cancer Chemotherapy by Infusion, 2nd ed, J Lokich. Precept Press, Chicago 1990; 35–41
- Mitchell R B, Ratain M J, Vogelzang N J. Experimental rationale for continuous infusion chemotherapy. Cancer Chemotherapy by Infusion, 2nd ed, J Lokich. Precept Press, Chicago 1990; 3–34
- Lokich J, Anderson N. Dose intensity for bolus versus infusion chemotherapy administration: review of the literature for 27 anti-neoplastic agents. Ann Oncol 1997; 8: 1–11
- Bertheault-Cvitkovic F, Jami A, Ithzaki M. Biweekly intensified ambulatory chronomodulated chemotherapy with oxa-liplatin, fluorouracil, and leucovorin in patients with metastatic colorectal cancer. J Clin Oncol 1996; 14: 2950–2958
- Legha S S. The anthracyclines and mitoxantrone. Cancer Cbemotherapy by Infusion, 2nd ed, J Lokich. Precept Press, Chicago 1990; 197–217
- Torti F M, Bristow M R, Howes A E. Reduced cardiotoxicity of doxorubicin delivered on a weekly schedule. Ann Intern Med 1983; 99: 745–749
- Hainsworth J D, Thompson D S, Greco F, Paclitaxel A. by one hour infusion an active drug in metastatic non-small-cell lung cancer. J Clin Oncol 1995; 13: 1609–1614